Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, Amphetamine Sulfate 00228-3062-11
- Manufacturer
- Actavis Pharma, Inc.
- Dosage Form
- Capsule, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CII
- Marketing Start
- June 22, 2012
- Listing Expires
- December 31, 2027
- Application
- ANDA077302
Active Ingredients
| Ingredient | Strength |
|---|---|
| Amphetamine Aspartate Monohydrate | 1.25 mg/1 |
| Amphetamine Sulfate | 1.25 mg/1 |
| Dextroamphetamine Saccharate | 1.25 mg/1 |
| Dextroamphetamine Sulfate | 1.25 mg/1 |
Drug Class
Central Nervous System Stimulant [EPC]Central Nervous System Stimulant [EPC]Central Nervous System Stimulant [EPC]
Selected Package
00228-3062-11Selected100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0228-3062-11)